Subscribe
Back to list

David Twitchell, PharmD

Senior Vice President and Chief Innovation Officer

Boston Medical Center Health System

Boston, MA

Mr. Twitchell is chief innovation officer at Boston Medical Center Health System, where he aligns operational strategy, equity and financial sustainability to expand access and improve outcomes. He redesigned inpatient operations and strengthened supply chain management, generating savings while improving care delivery performance. Mr. Twitchell helped grow pharmacy education and workforce pipelines by expanding training from fewer than 10 pharmacy students annually to nearly 200 and increasing residency positions from six to 13. He also spearheaded the buildout of specialty, mail order and hospital-based pharmacy services, growing revenue from $20 million to more than $1.1 billion annually while improving access to therapies for tens of thousands of patients, including in cancer and HIV care. He founded Clearway Health, a pharmacy solutions accelerator that has secured partnerships with 10 hospitals and health centers and supported complex access pathways for high-cost gene therapies. Mr. Twitchell additionally restructured pharmacy benefits operations, moving to a transparent pass-through pharmacy benefit manager model that saved more than $50 million in its first year across more than 700,000 health plan members in two states.

Becker's Recognition

David Twitchell, PharmDhas been named a Becker's honoree on the lists below.

2026 Winner

Executives

48 Hospital and Health System Chief Innovation Officers to Know

In the current age of accelerated digital transformation, chief innovation officers ensure that their hospitals and health systems remain on the cutting-edge of care delivery. Chief innovation officers foster cultures of innovation, creativity and open-mindedness, leading to novel technologies, enhanced patient care models, new partnerships and more.

Newsletter

Join the 500,000+
healthcare executives
who start their day with
Becker’s

You can unsubscribe from these communications at any time. For more information, please review
our Privacy Policy.
More Newsletters